LipoCoat ISO 13485 Certificate Extended Until March 2025

ISO 13485 Production Scope Expansion

Fabian Stein

January 24, 2022

Introduction

LipoCoat's ISO 13485 Quality Management System certificate has been successfully extended. ISO 13485 Certification ExtendedLipoCoat's ISO 13485 certificate has been extended through March 2025.

ISO 13485 Certification ExtendedLipoCoat's ISO 13485 certificate has been extended through March 2025. Crucially, 'production' has been added to the certified scope for design, development, and production of bio-inspired coatings.

ISO 13485:2016 Audit Reports

image of Jasper van Weerd CEO of Lipocoat

Fabian Stein

Chief Business Development Officer (CBDO)

Fabian Stein leads Business Development and Global Sales for the Lipocoat Company, connecting the coating platforms to medical device manufacturers.

Document

A coating inspired from the cell membrane: LipoCoat® in three applications

LipoCoat® is a 5 nm phospholipid coating that stops proteins and bacteria from adhering. What the new technology brochure shows for catheters, contact lenses and needles, and how it fits your production line.

Read post

News

Lipocoat celebrates its 10th anniversary and breaks ground on a new production lab in Enschede.

LipoCoat is building a 500-square-meter production lab across from the University of Twente and is marking its tenth anniversary. Constantijn van Oranje started construction.

Read post

Publication

SonoCoat® Technology Featured in Scientific Publications

Four independent peer-reviewed studies have evaluated SonoCoat®, from EUS-FNA needles to prostate brachytherapy. What each one tested, and what it found.

Read post

Introduction

Fabian Stein

Also interesting

A coating inspired from the cell membrane: LipoCoat® in three applications

Lipocoat celebrates its 10th anniversary and breaks ground on a new production lab in Enschede.

SonoCoat® Technology Featured in Scientific Publications